|
Immunotherapy
Citations 341-350 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia
- Jaroslaw P. Maciejewski, Elaine M. Sloand, Olga Nunez, Carol Boss, and Neal S. Young
Blood 2003; 102: 3584-3586.
[Abstract]
[Full text]
[PDF]
Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion
- Marie-Cécile Michallet, Frederic Saltel, Xavier Preville, Monique Flacher, Jean-Pierre Revillard, and Laurent Genestier
Blood 2003; 102: 3719-3726.
[Abstract]
[Full text]
[PDF]
The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma
- Peter Borchmann, John F. Treml, Hinrich Hansen, Claudia Gottstein, Roland Schnell, Oliver Staak, Hui-fen Zhang, Thomas Davis, Tibor Keler, Volker Diehl, Robert F. Graziano, and Andreas Engert
Blood 2003; 102: 3737-3742.
[Abstract]
[Full text]
[PDF]
Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia
- Chia-Rui Shen, Abdel-Rahman Youssef, Anne Devine, Laura Bowie, Andrew M. Hall, David C. Wraith, Christopher J. Elson, and Robert N. Barker
Blood 2003; 102: 3800-3806.
[Abstract]
[Full text]
[PDF]
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation
- Silvia Bozza, Katia Perruccio, Claudia Montagnoli, Roberta Gaziano, Silvia Bellocchio, Emanuela Burchielli, Gabriel Nkwanyuo, Lucia Pitzurra, Andrea Velardi, and Luigina Romani
Blood 2003; 102: 3807-3814.
[Abstract]
[Full text]
[PDF]
Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells
- Eric S. Yvon, Stephane Vigouroux, Raphael F. Rousseau, Ettore Biagi, Persis Amrolia, Gianpietro Dotti, Hans-Joachim Wagner, and Malcolm K. Brenner
Blood 2003; 102: 3815-3821.
[Abstract]
[Full text]
[PDF]
Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24
- Maurizio Chiriva-Internati, Yong Liu, Jon A. Weidanz, Fabio Grizzi, Hong You, Weiping Zhou, Klaus Bumm, Barthel Barlogie, Jawahar L. Mehta, and Paul L. Hermonat
Blood 2003; 102: 3100-3107.
[Abstract]
[Full text]
[PDF]
The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells
- Britta Maecker, David H. Sherr, Robert H. Vonderheide, Michael S. von Bergwelt-Baildon, Naoto Hirano, Karen S. Anderson, Zhinan Xia, Marcus O. Butler, Kai W. Wucherpfennig, Carl O'Hara, Geoffrey Cole, Silvia S. Kwak, Urban Ramstedt, Andy J. Tomlinson, Roman M. Chicz, Lee M. Nadler, and Joachim L. Schultze
Blood 2003; 102: 3287-3294.
[Abstract]
[Full text]
[PDF]
Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation
- Bertrand Dubois, Ludivine Chapat, Anne Goubier, Martine Papiernik, Jean-François Nicolas, and Dominique Kaiserlian
Blood 2003; 102: 3295-3301.
[Abstract]
[Full text]
[PDF]
CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects
- Unsu Jung, Jason E. Foley, Andreas A. Erdmann, Michael A. Eckhaus, and Daniel H. Fowler
Blood 2003; 102: 3439-3446.
[Abstract]
[Full text]
[PDF]
|
|
